Skip to main content
. 2016 Jun 1;8(1):49–57. doi: 10.1080/21541248.2016.1194952

Figure 3.

Figure 3.

A Cdc42-defective binding mutant of Cdc42EP3 acts as a dominant-negative when expressed in cancer-associated fibroblasts (CAFs). (A) Panels show GFP (green), F-actin (magenta) and DAPI (blue) staining of cancer-associated fibroblasts (CAFs) following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. The grayscale panels show individual channel magnifications of perinuclear areas. Scale bars, 25 μm. (B) Panels show GFP (green), SEPT2 (magenta) and DAPI (blue) staining of CAFs following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. The grayscale panels show individual channel magnifications of perinuclear areas. Scale bars, 25 μm. (C) Left panels show images of GFP (green), pS19-MLC2 (magenta) and DAPI (blue) staining of CAFs following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. Right panels show GFP (green), pY118-Paxillin (magenta) and DAPI (blue) staining of CAFs following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. Scale bars represent 25 μm.